(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Chaoju Eye Care Holdings Limited owns and operates a network of ophthalmic hospitals and optical centers in China. Its consumer ophthalmic services include treatments and prevention for various ophthalmic disorders, such as refractive and presbyopia correction, and myopia control, as well as optical products and services...
Stats | |
---|---|
Dagens volum | 450 500 |
Gjennomsnittsvolum | 1.25M |
Markedsverdi | 2.60B |
EPS | HKD0 ( 2024-03-28 ) |
Neste inntjeningsdato | ( HKD0 ) 2024-06-06 |
Last Dividend | HKD0.174 ( 2023-06-12 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 10.39 |
ATR14 | HKD0.00700 (0.19%) |
Volum Korrelasjon
Chaoju Eye Care Holdings Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Chaoju Eye Care Holdings Korrelasjon - Valuta/Råvare
Chaoju Eye Care Holdings Økonomi
Annual | 2023 |
Omsetning: | HKD1.37B |
Bruttogevinst: | HKD621.13M (45.35 %) |
EPS: | HKD0.330 |
FY | 2023 |
Omsetning: | HKD1.37B |
Bruttogevinst: | HKD621.13M (45.35 %) |
EPS: | HKD0.330 |
FY | 2022 |
Omsetning: | HKD990.04M |
Bruttogevinst: | HKD434.70M (43.91 %) |
EPS: | HKD0.270 |
FY | 2021 |
Omsetning: | HKD997.79M |
Bruttogevinst: | HKD448.67M (44.97 %) |
EPS: | HKD0.235 |
Financial Reports:
No articles found.
Chaoju Eye Care Holdings Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.174 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.104 | 2022-06-10 |
Last Dividend | HKD0.174 | 2023-06-12 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 2 | -- |
Total Paid Out | HKD0.278 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.03 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.93 | |
Div. Directional Score | 8.35 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
2377.HK | Ex Dividend Junior | 2023-06-15 | Annually | 0 | 0.00% | |
1358.HK | Ex Dividend Junior | 2023-09-29 | Annually | 0 | 0.00% | |
0400.HK | Ex Dividend Junior | 2023-06-13 | Sporadic | 0 | 0.00% | |
6690.HK | Ex Dividend Knight | 2023-07-24 | Annually | 0 | 0.00% | |
1907.HK | Ex Dividend Junior | 2023-09-08 | Semi-Annually | 0 | 0.00% | |
0939.HK | Ex Dividend Knight | 2023-07-06 | Annually | 0 | 0.00% | |
0064.HK | Ex Dividend Knight | 2023-08-29 | Semi-Annually | 0 | 0.00% | |
2885.HK | Ex Dividend Junior | 2023-06-15 | Annually | 0 | 0.00% | |
1503.HK | Ex Dividend Junior | 2023-09-13 | Semi-Annually | 0 | 0.00% | |
0553.HK | Ex Dividend Junior | 2023-07-03 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.167 | 1.500 | 6.66 | 9.99 | [0 - 0.5] |
returnOnAssetsTTM | 0.0783 | 1.200 | 7.39 | 8.87 | [0 - 0.3] |
returnOnEquityTTM | 0.0982 | 1.500 | -0.0200 | -0.0300 | [0.1 - 1] |
payoutRatioTTM | 0.479 | -1.000 | 5.21 | -5.21 | [0 - 1] |
currentRatioTTM | 5.05 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 3.34 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 1.352 | 1.500 | 3.60 | 5.40 | [0.2 - 2] |
debtRatioTTM | 0.0544 | -1.500 | 9.09 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 44.90 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.540 | 2.00 | 9.82 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.540 | 2.00 | 9.73 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0674 | -1.500 | 9.73 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.454 | 1.000 | 5.77 | 5.77 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.211 | 1.000 | 7.77 | 7.77 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 2.34 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.469 | 0.800 | -0.210 | -0.168 | [0.5 - 2] |
Total Score | 11.78 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 10.44 | 1.000 | 9.05 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0982 | 2.50 | -0.0128 | -0.0300 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.540 | 2.00 | 9.82 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 5.02 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.540 | 2.00 | 9.82 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.479 | 1.500 | 5.21 | -5.21 | [0 - 1] |
pegRatioTTM | 0.177 | 1.500 | -2.15 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.272 | 1.000 | 5.70 | 0 | [0.1 - 0.5] |
Total Score | 4.93 |
Chaoju Eye Care Holdings
Chaoju Eye Care Holdings Limited owns and operates a network of ophthalmic hospitals and optical centers in China. Its consumer ophthalmic services include treatments and prevention for various ophthalmic disorders, such as refractive and presbyopia correction, and myopia control, as well as optical products and services. The company also provides basic ophthalmic services, including cataract, glaucoma, ocular fundus diseases, ocular muscle diseases, refraction errors, pediatric ophthalmology, ocular surface diseases, lacrimal diseases, orbital diseases, oculoplastic, and ocular trauma. As of December 31, 2021, it operated a network of 17 ophthalmic hospitals, 24 optical centers, and 2 clinics in Zhejiang, Jiangsu, Shanxi, and Hebei provinces, as well as in Inner Mongolia. The company was founded in 1988 and is headquartered in Beijing, China.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.